Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat

Toxicological Sciences

Volumn 128, Issue 2, 2012, Pages 471-481

  Ahmadimoghaddam, Davoud ^a   Hofman, Jakub ^a   Zemankova, Lenka ^a   Nachtigal, Petr ^a   Dolezelova, Eva ^a   Cerveny, Lukas ^a   Ceckova, Martina ^a   Micuda, Stanislav ^b   Staud, Frantisek ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Multidrug and toxin extrusion transporter 1; Organic cation transporter 3; Pharmacokinetics; Placenta; Pregnancy

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CARRIER PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1; ORGANIC CATION TRANSPORTER 3; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; FETUS CIRCULATION; IMMUNOHISTOCHEMISTRY; KIDNEY; NONHUMAN; PH; PLACENTA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICOKINETICS; TROPHOBLAST; WESTERN BLOTTING;

EID: 84865396291     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs160     Document Type: Article

References (44)

1. Aleksunes, L. M., Cui, Y., and Klaassen, C. D. (2008). Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab. Dispos. 36, 1960-1970.
2. Bleasby, K., Chauhan, S., and Brown, C. D. (2000). Characterization of MPP? secretion across human intestinal Caco-2 cell monolayers: Role of P-glycoprotein and a novel Na(?)-dependent organic cation transport mechanism. Br. J. Pharmacol. 129, 619-625.
3. Brcakova, E., Fuksa, L., Cermanova, J., Kolouchova, G., Hroch, M., Hirsova, P., Martinkova, J., Staud, F., and Micuda, S. (2009). Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats. Biol. Pharm. Bull. 32, 1978-1985.
4. Ceckova-Novotna, M., Pavek, P., and Staud, F. (2006). P-glycoprotein in the placenta: Expression, localization, regulation and function. Reprod. Toxicol. 22, 400-410.
5. Cygalova, L. H., Hofman, J., Ceckova, M., and Staud, F. (2009). Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: Effect of drug efflux transporters and lipid solubility. J. Pharmacol. Exp. Ther. 331, 1118-1125.
6. Ganapathy, V., Ganapathy, M. E., Nair, C. N., Mahesh, V. B., and Leibach, F. H. (1988). Evidence for an organic cation-proton antiport system in brushborder membranes isolated from the human term placenta. J. Biol. Chem. 263, 4561-4568.
7. Ganapathy, V., and Prasad, P. D. (2005). Role of transporters in placental transfer of drugs. Toxicol. Appl. Pharmacol. 207, 381-387.
8. Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., et al. (2010). Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215-236.
9. Hahnova-Cygalova, L., Ceckova, M., and Staud, F. (2011). Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): Expression and function throughout pregnancy. Drug Metab. Rev. 43, 53-68.
10. Chen, W. S., Chang, H. Y., Chang, J. T., Liu, J. M., Li, C. P., Chen, L. L., Chang, H. L., Chen, C. C., and Huang, T. S. (2005). Novel rapid tissue lysis method to evaluate cancer proteins: Correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation. World J. Gastroenterol. 11, 5162-5168.
11. Ito, S., Kusuhara, H., Yokochi, M., Toyoshima, J., Inoue, K., Yuasa, H., and Sugiyama, Y. (2011). Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J. Pharmacol. Exp. Ther. 340, 393-403.
12. Jakoubek, V., Bibova, J., Herget, J., and Hampl, V. (2008). Chronic hypoxia increases fetoplacental vascular resistance and vasoconstrictor reactivity in the rat. Am. J. Physiol. Heart Circ. Physiol. 294, H1638-H1644.
13. Kekuda, R., Prasad, P. D., Wu, X., Wang, H., Fei, Y. J., Leibach, F. H., and Ganapathy, V. (1998). Cloning and functional characterization of a potentialsensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J. Biol. Chem. 273, 15971-15979.
14. Kertschanska, S., Stulcova, B., Kaufmann, P., and Stulc, J. (2000). Distensible transtrophoblastic channels in the rat placenta. Placenta 21, 670-677.
15. Koepsell, H., Lips, K., and Volk, C. (2007). Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24, 1227-1251.
16. Lee, W. K., Wolff, N. A., and Thevenod, F. (2009). Organic cation transporters: Physiology, toxicology and special focus on ethidium as a novel substrate. Curr. Drug Metab. 10, 617-631.
17. Martel, F., and Keating, E. (2003). Uptake of 1-methyl-4-phenylpyridinium (MPP?) by the JAR human placental choriocarcinoma cell line: Comparison with 5-hydroxytryptamine. Placenta 24, 361-369.
18. Martel, F., Martins, M. J., Hipolito-Reis, C., and Azevedo, I. (1996). Inward transport of [3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: Putative involvement of a P-glycoprotein transporter. Br. J. Pharmacol. 119, 1519-1524.
19. Masuda, S., Terada, T., Yonezawa, A., Tanihara, Y., Kishimoto, K., Katsura, T., Ogawa, O., and Inui, K. (2006). Identification and functional characterization of a new human kidney-specific H?/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J. Am. Soc. Nephrol. 17, 2127-2135.
20. Meller, M., Vadachkoria, S., Luthy, D. A., and Williams, M. A. (2005). Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26, 601-607.
21. Nies, A. T., Koepsell, H., Damme, K., and Schwab, M. (2011). Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the impor tance in drug therapy. Handb. Exp. Pharmacol. 201, 105-167.
22. Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., and Moriyama, Y. (2005). A human transporter protein that mediates the final excretion step for toxic organic cations. Proc. Natl. Acad. Sci. U.S.A. 102, 17923-17928.
23. Pavek, P., Fendrich, Z., Staud, F., Malakova, J., Brozmanova, H., Laznicek, M., Semecky, V., Grundmann, M., and Palicka, V. (2001). Influence of Pglycoprotein on the transplacental passage of cyclosporine. J. Pharm. Sci. 90, 1583-1592.
24. Pavek, P., Staud, F., Fendrich, Z., Sklenarova, H., Libra, A., Novotna, M., Kopecky, M., Nobilis, M., and Semecky, V. (2003). Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J. Pharmacol. Exp. Ther. 305, 1239-1250.
25. Radilova, H., Libra, A., Holasova, S., Safarova, M., Viskova, A., Kunc, F., and Buncek, M. (2009). COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells. Mol. Cell Biochem. 330, 131-140.
26. Sata, R., Ohtani, H., Tsujimoto, M., Murakami, H., Koyabu, N., Nakamura, T., Uchiumi, T., Kuwano, M., Nagata, H., Tsukimori, K., et al. (2005). Functional analysis of organic cation transporter 3 expressed in human placenta. J. Pharmacol. Exp. Ther. 315, 888-895.
27. Sayre, L. M. (1989). Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol. Lett. 48, 121-149.
28. Seidel, S. D., Hung, S. C., Lynn Kan, H., and Gollapudi, B. (2006). Background gene expression in rat kidney: Influence of strain, gender, and diet. Toxicol. Sci. 94, 226-233.
29. Sibley, C. P., Glazier, J. D., Greenwood, S. L., Lacey, H., Mynett, K., Speake, P., Jansson, T., Johansson, M., and Powell, T. L. (2002). Regulation of placental transfer: The Na(?)/H(?) exchanger-A review. Placenta 23(Suppl. A), S39-S46.
30. Simon, B. J., Kulanthaivel, P., Burckhardt, G., Ramamoorthy, S., Leibach, F. H., and Ganapathy, V. (1992). Characterization of an ATP-driven H? pump in human placental brush-border membrane vesicles. Biochem. J. 287(Pt 2), 423-430.
31. Soares, M. J., Schaberg, K. D., Pinal, C. S., De, S. K., Bhatia, P., and Andrews, G. K. (1987). Establishment of a rat placental cell line expressing characteristics of extraembryonic membranes. Dev. Biol. 124, 134-144.
32. Staud, F., Vackova, Z., Pospechova, K., Pavek, P., Ceckova, M., Libra, A., Cygalova, L., Nachtigal, P., and Fendrich, Z. (2006). Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J. Pharmacol. Exp. Ther. 319, 53-62.
33. Stulc, J., Stulcova, B., and Sibley, C. P. (1995). Mechanisms of the fetomaternal transfer of Na? across the dually perfused placenta of the rat. Placenta 16, 127-135.
34. Tanihara, Y., Masuda, S., Sato, T., Katsura, T., Ogawa, O., and Inui, K. (2007). Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(?)-organic cation antiporters. Biochem. Pharmacol. 74, 359-371.
35. Terada, T., and Inui, K. (2008). Physiological and pharmacokinetic roles of H?/organic cation antiporters (MATE/SLC47A). Biochem. Pharmacol. 75, 1689-1696.
36. Terada, T., Masuda, S., Asaka, J., Tsuda, M., Katsura, T., and Inui, K. (2006). Molecular cloning, functional characterization and tissue distribution of rat H?/organic cation antiporter MATE1. Pharm. Res. 23, 1696-1701.
37. Tertti, K., Ekblad, U., Heikkinen, T., Rahi, M., Ronnemaa, T., and Laine, K. (2010). The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta. Eur. J. Pharm. Sci. 39, 76-81.
38. Tsuda, M., Terada, T., Ueba, M., Sato, T., Masuda, S., Katsura, T., and Inui, K. (2009). Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells. J. Pharmacol. Exp. Ther. 329, 185-191.
39. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, 34.
40. Wang, X., Su, B., Liu, W., He, X., Gao, Y., Castellani, R. J., Perry, G., Smith, M. A., and Zhu, X. (2011). DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: Implications for Parkinson's disease. Aging Cell 10, 807-823.
41. Wu, X., Huang, W., Ganapathy, M. E., Wang, H., Kekuda, R., Conway, S. J., Leibach, F. H., and Ganapathy, V. (2000). Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am. J. Physiol. Renal. Physiol. 279, F449-F458.
42. Wu, X., Kekuda, R., Huang, W., Fei, Y. J., Leibach, F. H., Chen, J., Conway, S. J., and Ganapathy, V. (1998). Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273, 32776-32786.
43. Yonezawa, A., and Inui, K. (2011). Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/ toxicodynamics and pharmacogenomics. Br. J. Pharmacol. 164, 1817-1825.
44. Zwart, R., Verhaagh, S., Buitelaar, M., Popp-Snijders, C., and Barlow, D. P. (2001). Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol. Cell Biol. 21, 4188-4196.